Journal of Gastrointestinal Surgery

, Volume 15, Issue 1, pp 175–183 | Cite as

Analysis of 6,747 Pancreatic Neuroendocrine Tumors for a Proposed Staging System

  • Robert C. G. Martin
  • David A. Kooby
  • Sharon M. Weber
  • Nipun B. Merchant
  • Alex A. Parikh
  • Clifford S. Cho
  • Syed A. Ahmad
  • Hong Jin Kim
  • William Hawkins
  • Charles R. Scoggins
Original Article

Abstract

Objectives

Currently, no reasonable staging system exists for pancreatic neuroendocrine tumors (PNET) to guide treating physicians. The aim of this study was to devise a staging system of relevant prognostic factors to better predict overall survival in PNET.

Methods

A prospective 300 patient cohort and a review of the Surveillance Epidemiology and End Results database identified 6,447 patients with PNET from 1973 to 2008. Significant prognostic factors were created for an initial. Tumor: T (T1: ≤3 cm and localized to pancreas, T2: >3 cm and localized to the pancreas; T3: extension to adjacent organs and vessels), grade: G (G1: well/moderate and G2: poor/undifferentiated), and metastasis: M (M0: no distant mets, M1: distant mets) staging system.

Results

Significant predictors of survival on multivariate analysis included age, size, grade, and metastasis. Based on the TGM staging system: stage 1 (T1–2, G1, M0), stage 2 (T1–2, G2, M0), stage 3 (T3G2M0, Tany, G1, M1), stage 4: (Tany, G2, M1) was created with survival being statistically different between stages (p < 0.0001). Median survival rates were stage 1, 55 months; stage 2, 50 months; stage 3, 46 months; and stage 4, 25 months.

Conclusions

Incorporation of this newly developed staging system into clinical practice will improve the ability to predict prognosis and aid in stratification of patients for clinical trials.

Keywords

Pancreatic Neuroendocrine Staging 

References

  1. 1.
    Lam KY, Lo CY. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol 1997; 23:36–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Eriksson B, Oberg K. Neuroendocrine tumours of the pancreas. Br J Surg 2000; 87:129–131.PubMedCrossRefGoogle Scholar
  3. 3.
    Moldow RE, Connelly RR. Epidemiology of pancreatic cancer in Connecticut. Gastroenterology 1968; 55:677–686.PubMedGoogle Scholar
  4. 4.
    Capella C, Heitz PU, Hofler H et al. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 1995; 425:547–560.PubMedCrossRefGoogle Scholar
  5. 5.
    Rindi G, Capella C, Solcia E. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract. Q J Nucl Med 2000; 44:13–21.PubMedGoogle Scholar
  6. 6.
    Rindi G, Kloppel G, Alhman H et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449:395–401.PubMedCrossRefGoogle Scholar
  7. 7.
    Fischer L, Kleeff J, Esposito I et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008; 95:627–635.PubMedCrossRefGoogle Scholar
  8. 8.
    Bettini R, Boninsegna L, Mantovani W et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 2008; 19:903–908.PubMedCrossRefGoogle Scholar
  9. 9.
    La RS, Klersy C, Uccella S et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 2009; 40:30–40.CrossRefGoogle Scholar
  10. 10.
    Bilimoria KY, Bentrem DJ, Merkow RP et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg 2007; 205:558–563.PubMedCrossRefGoogle Scholar
  11. 11.
    Kaplan E, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53:457–481.CrossRefGoogle Scholar
  12. 12.
    Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Statistics in Medicine 2004; 23:723–748.PubMedCrossRefGoogle Scholar
  13. 13.
    Schemper M, Henderson R. Predictive Accuracy and explained variation in Cox regression. Biometrics 2000; 56:249–255.PubMedCrossRefGoogle Scholar
  14. 14.
    Heagerty P, Lumley T, Pepe M. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56:337–344.PubMedCrossRefGoogle Scholar
  15. 15.
    Efron B, Tibshirani R. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1994.Google Scholar
  16. 16.
    Lusa L, Miceli R, Mariani L. Estimation of predictive accuracy in survival analysis using R and S-PLUS. Computer Methods and Programs in Biomedicine 2007; 87:132–137.PubMedCrossRefGoogle Scholar
  17. 17.
    Heagerty P, Saha P. survivalROC: Time-dependent ROC curve estimation from censored survival data. 2006.Google Scholar
  18. 18.
    Canty A. Resampling Methods in R: The Boot Package. R News 2002; 2:2–7.Google Scholar
  19. 19.
    R Development Core Team. R: A language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.Google Scholar
  20. 20.
    Kooby DA, Gillespie T, Bentrem D et al. Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg 2008; 248:438–446.PubMedGoogle Scholar
  21. 21.
    Merchant N, Ayers GD, Schmidt CM, Kooby DA, Kim HJ, Weber SM, Martin RCG, Ahmed S, Sharp KS, Beauchamp RD, Parikh AA. Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? J Am Coll.Surg. 2009: 208(5):829–838; discussion 838–841Google Scholar
  22. 22.
    Weber SM, Cho CS, Merchant N et al. Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol 2009; 16:2825–2833.PubMedCrossRefGoogle Scholar
  23. 23.
    Schindl M, Kaczirek K, Kaserer K et al. Is the new classification of neuroendocrine pancreatic tumors of clinical help? World J Surg 2000; 24:1312–1318.PubMedCrossRefGoogle Scholar
  24. 24.
    Landry CS, Brock G, Scoggins CR et al. Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients. J Am Coll Surg 2008; 207:874–881.PubMedCrossRefGoogle Scholar
  25. 25.
    Landry CS, Brock G, Scoggins CR et al. A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg 2008; 196:896–903.PubMedCrossRefGoogle Scholar
  26. 26.
    Landry CS, Brock G, Scoggins CR et al. A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol 2009; 16:51–60.PubMedCrossRefGoogle Scholar
  27. 27.
    Landry CS, Brock G, Scoggins CR et al. A proposed staging system for rectal carcinoid tumors based on an analysis of 4,701 patients. Surgery 2008; 144:460–466.PubMedCrossRefGoogle Scholar
  28. 28.
    Landry CS, Woodall C, Scoggins CR et al. Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg 2008; 143:664–670.PubMedCrossRefGoogle Scholar
  29. 29.
    Landry CS, McMasters KM, Scoggins CR et al. Proposed staging system for gastrointestinal carcinoid tumors. Am Surg 2008; 74:418–422.PubMedGoogle Scholar
  30. 30.
    Kazanjian KK, Reber HA, Hines OJ. Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg 2006; 141:765–769.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2010

Authors and Affiliations

  • Robert C. G. Martin
    • 1
    • 8
  • David A. Kooby
    • 2
  • Sharon M. Weber
    • 3
  • Nipun B. Merchant
    • 4
  • Alex A. Parikh
    • 4
  • Clifford S. Cho
    • 3
  • Syed A. Ahmad
    • 5
  • Hong Jin Kim
    • 6
  • William Hawkins
    • 7
  • Charles R. Scoggins
    • 1
  1. 1.Department of SurgeryUniversity of Louisville HospitalLouisvilleUSA
  2. 2.Department of SurgeryEmory University HospitalAtlantaUSA
  3. 3.Department of SurgeryUniversity of Wisconsin HospitalMadisonUSA
  4. 4.Department of SurgeryVanderbilt University Medical CenterNashvilleUSA
  5. 5.Department of SurgeryUniversity of Cincinnati Medical CenterCincinnatiUSA
  6. 6.Department of SurgeryUniversity of North Carolina HospitalsChapel HillUSA
  7. 7.Department of SurgeryWashington University Medical CenterSt. LouisUSA
  8. 8.Department of SurgeryUniversity of Louisville School of MedicineLouisvilleUSA

Personalised recommendations